Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @PhaseBio
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @PhaseBio
-
$PHAS announces case study highlighting hemodynamic data that supports the potential of PB1046, a once-weekly VIP analogue for adults with pulmonary arterial hypertension and was presented at the 14th PVRI World Congress.#PAH#PVRI2020https://investors.phasebio.com/news-releases/news-release-details/phasebio-announces-case-study-highlighting-pb1046-hemodynamic …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
$PHAS announces acquisition of novel oral aldosterone synthase inhibitor to develop for treatment-resistant#hypertension.https://investors.phasebio.com/news-releases/news-release-details/phasebio-announces-acquisition-novel-oral-aldosterone-synthase …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today, we announced a financing and co-development collaboration with SFJ Pharmaceuticals® for PB2452.
$PHAShttps://investors.phasebio.com/news-releases/news-release-details/phasebio-announces-financing-and-co-development-collaboration …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Want to learn more about
#PulmonaryArterialHypertension? Check out this@phaware podcast to learn more about$PHAS PB1046, a once weekly treatment we are developing for adults struggling with#PAH.https://phasebio.com/pipeline/pb1046/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Dr. Harold Palevsky discusses
$PHAS once-weekly VIP analogue PB1046 that is currently in clinical trials for adults struggling with#PulmonaryArterialHypertension. Listen to the@phaware podcast here.#PAHhttps://medium.com/@phaware/im-aware-that-i-m-rare-harold-i-palevsky-md-305-d73cdc4b7a0d …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Cardiologist Dr. Raymond Benza discusses
#PulmonaryArterialHypertension and$PHAS once weekly VIP analogue PB1046 currently in clinical trials for adults with#PAH. Listen to the@phaware podcast here.https://link.medium.com/EDXXBK4D21Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Have you heard pulmonologist Dr. Harold Palevsky discuss
$PHAS once weekly VIP analogue PB1046 that is currently in clinical trials for adults struggling with#PulmonaryArterialHypertension? Listen to the@phaware podcast here.#PAHhttps://phasebio.com/pipeline/pb1046/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you
@ASH_hematology for another educational#ASH19 meeting.$PHAS looks forward to#ASH20 and sharing updates on PB2452, a novel reversal agent for the#antiplatelet drug#ticagrelor.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Listen to the latest “I’m Aware That I’m Rare” phaware podcast that talks about our once weekly VIP analogue PB1046 for adult patients struggling with pulmonary arterial hypertension.
#PAHhttps://phawarepodcast.libsyn.com/episode-305-harold-palevsky-md …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are in Orlando for
#ASH19 and looking forward to hearing the latest scientific updates from@ASH_hematology. Want to know more about us, including our work to develop a novel reversal agent for the#antiplatelet drug#ticagrelor?$PHAS Check outhttps://phasebio.com/pb2452/Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#ASH19#DYK$PHAS is developing a novel reversal agent for the#antiplatelet drug#ticagrelor? Learn more about PB2452:https://phasebio.com/pipeline/pb2452/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Missed yesterday’s
@phaware podcast about adult patients struggling#PulmonaryArterialHypertension with Dr. Palevsky? Check out the transcript here.http://phawarepodcast.libsyn.com/harold-palevsky-md-phaware-interview-305 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PhaseBio proslijedio/la je Tweet
Dr. Harold Palevsky discusses a new molecule on the forefront of treatment for pulmonary arterial hypertension called PB1046 and the positive effects it could have for the PAH community.
@phaware podcast ep 305#phaware#phawareMD@PhaseBiohttp://traffic.libsyn.com/phawarepodcast/Harold_Palevsky_MD_phaware_podcast_Ep_305.mp3?dest-id=420473 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Stay tuned for an upcoming
@phaware podcast featuring pulmonologist Dr. Harold Palevsky discussing adult patients struggling with#PulmonaryArterialHypertension going live on Thursday, 12/5.#PAHHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Have you heard cardiologist Dr. Raymond Benza discuss
$PHAS long-acting VIP analogue PB1046 for adults struggling with#PulmonaryArterialHypertension? Listen to the@phaware podcast here.#PAHhttps://phasebio.comHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Listen to the latest
@phaware podcast to learn more about$PHAS long-acting VIP analogue PB1046 for adults struggling with#PulmonaryArterialHypertension.#PAH#PHAwarenessMonthhttps://phasebio.com/clinical-trialsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Missed yesterday’s
@phaware podcast on#PulmonaryArterialHypertension? Check out the transcript here.#PAH#PHAwarenessMonthhttp://phawarepodcast.libsyn.com/raymond-benza-md-phaware-interview-303 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
PhaseBio proslijedio/la je Tweet
Dr. Raymond Benza discusses the importance of
#clinicaltrials in patients with pulmonary arterial hypertension including a new molecule that's on the forefront of treatment for PAH called PB1046.@phaware podcast 303#phaware#phawareMD@PhaseBiohttp://traffic.libsyn.com/phawarepodcast/Ray_Benza_MD_phaware_podcast_Ep_303.mp3?dest-id=420473 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Learn more about
$PHAS PB1046, a once-weekly treatment we are developing for adults struggling with#PulmonaryArterialHypertension.#PHAwarenessMonthhttps://phasebio.com/pipeline/pb1046Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Stay tuned for an upcoming
@phaware podcast featuring cardiologist Dr. Raymond Benza discussing#PulmonaryArterialHypertension going live on Thursday, 11/28.#PHAwarenessMonthHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.